Creative Medical Technology Holdings, Inc. (CELZ) Stock Forecast
CELZ analyst forecast
as of October 18, 2026- Analyst consensus
- Strong buy 5.00 / 5 from 1 analysts
- Price target
- $20.00 average of analyst targets
- Upside to target
- +2,599.1% from the latest close
- Next earnings
- November 6, 2026 EPS estimate $-0.24
- 52-week range
- $0.65 – $5.59
CELZ analyst ratings
1 analystsNumber of analysts at each rating.
CELZ price target
The average of analyst 12-month price targets compared with the latest close and the 52-week range.
CELZ earnings per share estimates
| Period | Average | Low | High | Year ago | Growth | Analysts |
|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | −$0.24 | −$0.24 | −$0.24 | −$0.48 | +50.0% | 1 |
| Current fiscal year (2026) | −$1.18 | −$1.18 | −$1.18 | −$2.52 | +53.2% | 1 |
| Next fiscal year (2027) | −$0.88 | −$0.88 | −$0.88 | −$1.18 | +25.4% | 1 |
Consensus EPS estimates; growth compares the average estimate with the year-ago EPS.
CELZ revenue estimates
| Period | Average | Low | High | Growth | Analysts |
|---|---|---|---|---|---|
| Current quarter (Sep '26) | $0 | $0 | $0 | 0.0% | 1 |
| Current fiscal year (2026) | $0 | $0 | $0 | −100.0% | 1 |
| Next fiscal year (2027) | $0 | $0 | $0 | 0.0% | 1 |
CELZ EPS: reported and forecast
Fiscal years; "E" marks estimates, the line shows the range from the lowest to the highest estimate.
CELZ EPS estimate revisions
| Period | 90 days ago | 60 days ago | 30 days ago | 7 days ago | Now | Change (90 d) | Revisions (30 d) |
|---|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | −$0.40 | −$0.40 | −$0.23 | −$0.24 | −$0.24 | −40.0% | 0 up · 1 down |
| Current fiscal year (2026) | −$1.57 | −$1.57 | −$1.14 | −$1.18 | −$1.18 | −24.8% | 0 up · 1 down |
| Next fiscal year (2027) | −$1.51 | −$1.51 | −$0.86 | −$0.88 | −$0.88 | −41.7% | 0 up · 1 down |
How the consensus EPS estimate changed over the last 90 days, and how many analysts raised or lowered it in the last 30 days.
CELZ earnings surprises
Reported EPS vs the consensus estimate for the last 12 quarters; CELZ beat in 5 of 12.
What analysts expect from CELZ
1 analysts cover Creative Medical Technology; their consensus rating is strong buy (5.00 on a 1–5 scale, where 5 is a strong buy). The average price target is $20.00, 2,599.1% above the latest close of $0.74. Analysts expect earnings of −$1.18 per share for 2026, +53.2% from a year earlier. For 2027 the average estimate is −$0.88 per share. Creative Medical Technology beat the EPS estimate in 5 of the last 12 quarters.
Related: CELZ income statement, CELZ key metrics, CELZ chart. See the CELZ stock overview for the latest quote and news.
CELZ forecast FAQ
What is Creative Medical Technology's price target?
The average analyst price target for Creative Medical Technology is $20.00, 2,599.1% above the latest close of $0.74.
Is Creative Medical Technology a buy, hold or sell?
Of 1 analysts covering Creative Medical Technology, 1 rate it a strong buy, 0 a buy, 0 a hold, 0 a sell and 0 a strong sell, a consensus of strong buy. Ratings are opinions, not a recommendation from Quotelinks.
What is Creative Medical Technology's EPS forecast?
Analysts forecast −$1.18 per share for 2026 (range −$1.18 to −$1.18); for 2027 the estimate is −$0.88.
When does Creative Medical Technology report earnings?
Creative Medical Technology is expected to report results for the quarter ending September 30, 2026 on November 6, 2026; the EPS estimate is $-0.24.
Does Creative Medical Technology usually beat earnings estimates?
Creative Medical Technology reported EPS at or above the analyst estimate in 5 of the last 12 quarters.